Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder
Revolutionizing Treatment for Congenital Generalized Lipodystrophy (CGL) Recent advancements in medical research have uncovered promising new treatments for Congenital Generalized Lipodystrophy (CGL), a rare genetic disorder that leaves patients with almost no fat tissue. A new study highlights the potential of once-weekly tirzepatide injections to replace daily hormone shots, marking a significant leap in patient … Read more